Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 4 boards, counting each seat separately. Longest: Inogen Inc, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Bioventus Inc. June 3, 202698.0%
-
Novanta Inc. May 28, 202697.8%
-
Novanta Inc. May 29, 202598.2%
-
Inogen Inc May 14, 202569.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 9, 2026 | Kestra Medical Technologies Ltd. | Grant or award | +7,217 | — | — |
| Sep 8, 2026 | Kestra Medical Technologies Ltd. | Open-market sale | −3,908 | $25.20 | $98,482 |
| Jun 5, 2026 | Inogen Inc | Grant or award | +28,081 | — | — |
| Jun 2, 2026 | Bioventus Inc. | Option exercise | +32,282 | — | — |
| Jan 2, 2026 | Novanta Inc. | Option exercise | +1,325 | — | — |
| Sep 4, 2025 | Kestra Medical Technologies Ltd. | Grant or award | +10,909 | — | — |
| Jul 11, 2025 | Novanta Inc. | Option exercise | +572 | — | — |
| Jun 2, 2025 | Bioventus Inc. | Option exercise | +26,493 | — | — |
| May 14, 2025 | Inogen Inc | Grant or award | +30,612 | — | — |
| Jun 16, 2024 | Bioventus Inc. | Option exercise | +1,814 | — | — |
| Jun 7, 2024 | Bioventus Inc. | Option exercise | +30,400 | — | — |
| Jun 5, 2024 | Inogen Inc | Grant or award | +21,871 | — | — |
| Jun 16, 2023 | Bioventus Inc. | Option exercise | +1,813 | — | — |
| Jun 6, 2023 | Bioventus Inc. | Option exercise | +16,648 | — | — |
| May 31, 2023 | Inogen Inc | Grant or award | +17,094 | — | — |
Questions about Mary Kay Ladone
What boards is Mary Kay Ladone on?
Mary Kay Ladone sits on the boards of Bioventus Inc., Inogen Inc, Kestra Medical Technologies Ltd. and Novanta Inc.
How long has Mary Kay Ladone served on boards?
Our records show at least 11 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.